These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 15458436)

  • 1. Selective lymphocyte inhibition by FTY720 slows the progressive course of chronic anti-thy 1 glomerulosclerosis.
    Peters H; Martini S; Wang Y; Shimizu F; Kawachi H; Krämer S; Neumayer HH
    Kidney Int; 2004 Oct; 66(4):1434-43. PubMed ID: 15458436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The lymphocyte migration inhibitor FTY720 attenuates experimental hypertensive nephropathy.
    Krämer S; Binder E; Loof T; Wang-Rosenke Y; Martini S; Khadzhynov D; Budde K; Neumayer HH; Peters H
    Am J Physiol Renal Physiol; 2009 Jul; 297(1):F218-27. PubMed ID: 19439518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of soluble guanylate cyclase slows progression in anti-thy1-induced chronic glomerulosclerosis.
    Wang Y; Krämer S; Loof T; Martini S; Kron S; Kawachi H; Shimizu F; Neumayer HH; Peters H
    Kidney Int; 2005 Jul; 68(1):47-61. PubMed ID: 15954895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S1P modulator FTY720 limits matrix expansion in acute anti-thy1 mesangioproliferative glomerulonephritis.
    Martini S; Krämer S; Loof T; Wang-Rosenke Y; Daig U; Budde K; Neumayer HH; Peters H
    Am J Physiol Renal Physiol; 2007 Jun; 292(6):F1761-70. PubMed ID: 17356129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycophenolate mofetil slows progression in anti-thy1-induced chronic renal fibrosis but is not additive to a high dose of enalapril.
    Krämer S; Loof T; Martini S; Rückert M; Wang Y; Böhler T; Shimizu F; Kawachi H; Neumayer HH; Peters H
    Am J Physiol Renal Physiol; 2005 Aug; 289(2):F359-68. PubMed ID: 15769934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose mTOR inhibition by rapamycin attenuates progression in anti-thy1-induced chronic glomerulosclerosis of the rat.
    Krämer S; Wang-Rosenke Y; Scholl V; Binder E; Loof T; Khadzhynov D; Kawachi H; Shimizu F; Diekmann F; Budde K; Neumayer HH; Peters H
    Am J Physiol Renal Physiol; 2008 Feb; 294(2):F440-9. PubMed ID: 18094032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [FTY720 attenuates rat anti-Thy-1 mesangial proliferative glomerulonephritis by inhibition of transforming growth factor β1-connective tissue growth factor pathway].
    Jiang JY; Huang XD; Wang Y; Deng AP; Zhou JH
    Zhonghua Bing Li Xue Za Zhi; 2012 Feb; 41(2):107-11. PubMed ID: 22455887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of FTY720 on chronic cyclosporine nephropathy in rats.
    Kim JY; Lim SW; Li C; Kim JS; Ahn KO; Yang HJ; Choi BS; Kim YS; Kim J; Bang BK; Yang CW
    Transplantation; 2005 Nov; 80(9):1323-30. PubMed ID: 16314802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FTY720 attenuates tubulointerstitial inflammation and fibrosis in subtotally nephrectomized rats.
    Ni HF; Chen JF; Zhang MH; Pan MM; Zhang JD; Liu H; Tang RN; Ma KL; Liu BC
    Ren Fail; 2013 Aug; 35(7):996-1004. PubMed ID: 23848241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of FTY720 on M1 and M2 macrophages, lymphocytes, and chemokines in 5/6 nephrectomized rats.
    Schaier M; Vorwalder S; Sommerer C; Dikow R; Hug F; Gross ML; Waldherr R; Zeier M
    Am J Physiol Renal Physiol; 2009 Sep; 297(3):F769-80. PubMed ID: 19535570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of FTY720 on glomerulosclerosis and expression of cell cycle regulatory proteins in subtotally nephrectomized rats].
    Zhu GQ; Zhou JH; Xie M; Hao Y
    Zhonghua Er Ke Za Zhi; 2007 Dec; 45(12):922-6. PubMed ID: 18339282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effects of FTY720 on chronic allograft nephropathy by reducing late lymphocytic infiltration.
    Wang M; Liu S; Ouyang N; Song E; Lutz J; Heemann U
    Kidney Int; 2004 Sep; 66(3):1248-56. PubMed ID: 15327424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FTY720 reduces extracellular matrix expansion associated with ischemia-reperfusion induced injury.
    Delbridge MS; Shrestha BM; Raftery AT; El Nahas AM; Haylor J
    Transplant Proc; 2007 Dec; 39(10):2992-6. PubMed ID: 18089307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancing cGMP in experimental progressive renal fibrosis: soluble guanylate cyclase stimulation vs. phosphodiesterase inhibition.
    Wang Y; Krämer S; Loof T; Martini S; Kron S; Kawachi H; Shimizu F; Neumayer HH; Peters H
    Am J Physiol Renal Physiol; 2006 Jan; 290(1):F167-76. PubMed ID: 16048904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rosuvastatin is additive to high-dose candesartan in slowing progression of experimental mesangioproliferative glomerulosclerosis.
    Krämer S; Kron S; Wang-Rosenke Y; Loof T; Khadzhynov D; Morgera S; Kawachi H; Shimizu F; Martini S; Neumayer HH; Peters H
    Am J Physiol Renal Physiol; 2008 Apr; 294(4):F801-11. PubMed ID: 18216152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tyrosine kinases inhibition by Imatinib slows progression in chronic anti-thy1 glomerulosclerosis of the rat.
    Wang-Rosenke Y; Khadzhynov D; Loof T; Mika A; Kawachi H; Neumayer HH; Peters H
    BMC Nephrol; 2013 Oct; 14():223. PubMed ID: 24119229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FTY720 prevents progression of renal fibrosis by inhibiting renal microvasculature endothelial dysfunction in a rat model of chronic kidney disease.
    Ni H; Chen J; Pan M; Zhang M; Zhang J; Chen P; Liu B
    J Mol Histol; 2013 Dec; 44(6):693-703. PubMed ID: 23907620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting tubulointerstitial remodeling in proteinuric nephropathy in rats.
    Yazdani S; Hijmans RS; Poosti F; Dam W; Navis G; van Goor H; van den Born J
    Dis Model Mech; 2015 Aug; 8(8):919-30. PubMed ID: 26035383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FTY720, an immunosuppressant, attenuates chronic pancreatitis in rats by suppressing T-cell infiltration.
    Okamoto T; Yamada T; Kuno A; Ogawa K; Tang M; Sano H; Ohara H; Nakao H; Kataoka H; Shirai T; Itoh M
    Pancreas; 2005 Apr; 30(3):e64-70. PubMed ID: 15782091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Divergent effects of low versus high dose anti-TGF-beta antibody in puromycin aminonucleoside nephropathy in rats.
    Ma LJ; Jha S; Ling H; Pozzi A; Ledbetter S; Fogo AB
    Kidney Int; 2004 Jan; 65(1):106-15. PubMed ID: 14675041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.